Valproic acid triggers acute rhabdomyolysis in a patient with carnitine palmitoyltransferase type II deficiency

Neuromuscular Disorders

Volumn 11, Issue 8, 2001, Pages 757-759

  Kottlors, Michael ^a,d   Jaksch, Michaela ^b   Ketelsen, Uwe Peter ^c   Weiner, Stefan ^a   Glocker, Franz Xaver ^a   Lücking, Carl Hermann ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Klinikum Schwabing   (Germany)

^c Children's Hospital   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Carnitine; Carnitine palmitoyltransferase deficiency; Rhabdomyolysis; Valproic acid

Indexed keywords

ACYLCARNITINE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE II; DOPAMINE; LITHIUM; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; ALLELE; ARTICLE; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENETIC ANALYSIS; HUMAN; KIDNEY FAILURE; LIPID STORAGE; MALE; MANIC DEPRESSIVE PSYCHOSIS; MUSCLE BIOPSY; MYOGLOBINURIA; PRIORITY JOURNAL; RHABDOMYOLYSIS; SKELETAL MUSCLE;

ACETYLCARNITINE; ACUTE DISEASE; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARNITINE O-PALMITOYLTRANSFERASE; HUMANS; LIPID METABOLISM, INBORN ERRORS; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; MUTATION; MYOGLOBINURIA; RHABDOMYOLYSIS; VALPROIC ACID;

EID: 0034815422     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(01)00228-0     Document Type: Article

References (14)

1. Valproate and cytochrome c oxidase deficiency
2. Late onset lipid storage myopathy due to multiple acyl CoA dehydrogenase deficiency triggered by valproate
3. Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency
4. In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions
5. Beta-oxidation of fatty acids
6. Mitochondrial fatty acid disorders
7. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients
8. Adult carnitine palmitoyltransferase II deficiency: Detection of characteristic carnitine esters in serum by tandem mass spectrometry
9. Muscle carnitine deficiency in patients using valproic acid
10. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy
11. Valproic acid-induced increase in carnitine acetyltransferase in rat hepatocytes is not due to an induction of peroxisomes
12. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies
13. Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of the free acids and their carnitine esters on coenzyme A-dependent oxidations in rat liver mitochondria
14. Carnitine palmitoyltransferase II specificity towards beta-oxidation intermediates - Evidence for a reverse carnitine cycle in mitochondria